Close Menu
John Mahama News
  • Home
  • Ghana News
  • Anti-Corruption
    • Corruption Watch
  • Economic
    • Education & Innovation
  • Environmental
    • Governance & Policy
  • Health & Welfare
    • Historical & Cultural Insights
    • Infrastructure & Development
    • International Relations
  • Ministerial News
    • Presidential Updates
  • Public Opinion
    • Regional Governance
      • Social Issues & Advocacy
      • Youth & Sports
What's Hot

Cedi sells at GHS12.35 on forex market, GHS10.36 interbank on July 9

July 9, 2025

Chelsea’s New Chapter Unfolding Before Our Eyes. A Journey Built on Youth, Grit, and Unexpected Glory

July 9, 2025

Maintain integrity, curb police excesses in anti-galamsey operations

July 9, 2025
Facebook X (Twitter) Instagram
Trending
  • Cedi sells at GHS12.35 on forex market, GHS10.36 interbank on July 9
  • Chelsea’s New Chapter Unfolding Before Our Eyes. A Journey Built on Youth, Grit, and Unexpected Glory
  • Maintain integrity, curb police excesses in anti-galamsey operations
  • 2.2 million Ghanaians’ eye fails to focus light properly on the retina, resulting in blurred vision – Prof. Boadi-Kusi 
  • Ghana’s CEOs’ optimism and appetite for GenAI risen rapidly – PwC CEO Survey
  • The United States and Israel will make new attempts to attack Iran
  • 1D1F scrapped
  • ‘The law is about common sense and common sense is the law’
  • Home
  • About Us
  • Advertise With Us
  • Contact Us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
Facebook X (Twitter) Instagram
John Mahama News
Wednesday, July 9
  • Home
  • Ghana News
  • Anti-Corruption
    • Corruption Watch
  • Economic
    • Education & Innovation
  • Environmental
    • Governance & Policy
  • Health & Welfare
    • Historical & Cultural Insights
    • Infrastructure & Development
    • International Relations
  • Ministerial News
    • Presidential Updates
  • Public Opinion
    • Regional Governance
      • Social Issues & Advocacy
      • Youth & Sports
John Mahama News
Home » First malaria treatment for babies approved for use

First malaria treatment for babies approved for use

johnmahamaBy johnmahamaJuly 9, 2025 Ministerial News No Comments4 Mins Read
Share
Facebook Twitter LinkedIn Pinterest Email


The first malaria treatment suitable for babies and very young children has been approved for use.

It’s expected to be rolled out in African countries within weeks.

Until now there have been no approved malaria drugs specifically for babies.

Instead they have been treated with versions formulated for older children which presents a risk of overdose.

Half a million deaths in 2023

In 2023 – the year for which the most recent figures are available – malaria was linked to around 597,000 deaths.

Almost all of the deaths were in Africa, and around three quarters of them were children under five years old.

Malaria treatments for children do exist but until now, there was none specifically for the very youngest babies and small children, who weigh less than 4.5kg or around 10lb.

Instead they have been treated with drugs designed for older children.

But that presents risks, as doses for these older children may not be safe for babies, whose liver functions are still developing and whose bodies process medicines differently.

Experts say this has led to what is described as a “treatment gap”.

Now a new medicine, developed by the drug company Novartis, has been approved by the Swiss authorities and is likely to be rolled out in regions and countries with the highest rates of malaria within weeks.

Novartis is planning to introduce it on a largely not-for-profit basis.

The smallest and most vulnerable

The company’s chief executive, Vas Narasimhan, says this is an important moment.

“For more than three decades, we have stayed the course in the fight against malaria, working relentlessly to deliver scientific breakthroughs where they are needed most.

“Together with our partners, we are proud to have gone further to develop the first clinically proven malaria treatment for newborns and young babies, ensuring even the smallest and most vulnerable can finally receive the care they deserve.”

The drug, known as Coartem Baby or Riamet Baby in some countries, was developed by Novartis in collaboration with the Medicines for Malaria Venture (MMV), a Swiss-based not-for-profit organisation initially backed by the British, Swiss and Dutch Governments, as well as the World Bank and the Rockefeller Foundation.

Eight African nations also took part in the assessment and trials of the drug and they are expected to be among the first to access it.

Martin Fitchet, CEO of MMV, says this is another important step on the road towards ending the huge toll taken by malaria.

“Malaria is one of the world’s deadliest diseases, particularly among children. But with the right resources and focus, it can be eliminated.

“The approval of Coartem Baby provides a necessary medicine with an optimised dose to treat an otherwise neglected group of patients and offers a valuable addition to the antimalarial toolbox.”

Dr Marvelle Brown, associate professor at the University of Hertfordshire’s School of Health, Medicine and Life Sciences, says this should be seen as a major breakthrough in saving the lives of babies and young children.

“The death rate for malarial infections, particularly in sub-Saharan Africa is extremely high – over 76% of deaths occur in children under five years old.

“Increase in death from malaria is further compounded in babies born with sickle cell disease, primarily due to a weak immune system.

“From a public health perspective, Novartis making this not-for-profit can help with reducing inequality in access to healthcare.”

DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.


Tags:  

DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.



Source link

johnmahama
  • Website

Keep Reading

KNUST Optometry 8th White Coat Ceremony tackles refractive error setbacks to improve access

Africa set to advance cancer care as UHAS launches postgraduate certificate programme

US delays higher tariffs but announces new rates for some nations

Measles cases in the US reach 33-year high

King says France and UK face ‘complex threats’

Volta Council of State member pledges GH₵60k borehole for Sokode Ando community

Add A Comment
Leave A Reply Cancel Reply

Editors Picks

Cedi sells at GHS12.35 on forex market, GHS10.36 interbank on July 9

July 9, 2025

Ghana set to reap windfall from surging gold prices — Fitch Solutions forecasts record current account surplus

July 9, 2025

Dr. Agyepong Urges African Business Leaders to Unite for the Continent’s Economic Independence

July 8, 2025

IMF names Dr. Adrian Alter as new resident rep to Ghana amid ongoing economic reforms

July 8, 2025
Latest Posts

Complacency exposes Africa to cybercrime

July 8, 2025

How 25 Nigerians were trafficked to Ghana, forced into large scale fraudulent activities from their Dodowa hideout

July 8, 2025

AI Training, SIM reforms and internet upgrades

July 3, 2025

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Welcome to JohnMahama.news, your trusted source for the latest news, insights, and updates about the President of Ghana, government policies, and the nation at large. Our mission is to provide accurate, timely, and comprehensive coverage of all things related to the leadership of Ghana, as well as key national issues that impact citizens and communities across the country.

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

Facebook X (Twitter) Instagram Pinterest
  • Home
  • About Us
  • Advertise With Us
  • Contact Us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
© 2025 johnmahama. Designed by johnmahama.

Type above and press Enter to search. Press Esc to cancel.